By Topic

Method for quantitative assessment of tumor volume response to neoadjuvant chemotherapy using MRI

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
Partridge, S. ; Joint Graduate Group in Bioeng., California Univ., Berkeley, CA, USA ; Esserman, L. ; Kaplan, E. ; Heumann, E.
more authors

Neoadjuvant chemotherapy is an effective treatment for locally advanced breast cancer (LABC). Response of a tumor to preoperative chemotherapy is a valuable predictor of a patient's overall survival. We hypothesize that magnetic resonance imaging (MRI) may be more predictive of patient outcome than clinical examination by providing quantitative assessments of the extent of cancer in the breast and the change in response to neoadjuvant treatment. The purpose of this study was to investigate whether MRI can accurately quantify changes in tumor size in response to treatment. MRI size measurements were compared to clinical response assessments and post-surgical pathology data in a group of women with LABC. The MR techniques accurately characterized the size of the residual disease in the breast and demonstrated predictive value for treatment outcome

Published in:

Engineering in Medicine and Biology Society, 2000. Proceedings of the 22nd Annual International Conference of the IEEE  (Volume:3 )

Date of Conference: